January 20, 2021
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., issued the following statement.
Healthcare Distribution Alliance – Patients Move Us.
SEARCH
News
FEATURED NEWS
HDA-Supported Pilot Results in Successful Automation of Authorized Trading Partner Credentialing for DSCSA
March 30, 2021
The Healthcare Distribution Alliance (HDA), in coordination with the Center for Supply Chain Studies, announced the successful conclusion of an industry-wide pilot of an interoperable “authorized trading...
‘Health Delivered’ Campaign Spotlights Integral Role of Distributors in Response To COVID-19 and Beyond
March 22, 2021
The Healthcare Distribution Alliance (HDA) today launched a campaign — “Health Delivered” — to communicate the healthcare distribution industry’s integral role and logistics expertise during the COVID-19...
HDA Statement on Enactment of The American Rescue Plan
March 11, 2021
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to today’s enactment of The American Rescue Plan Act of 2021 by President Biden.
HDA Statement on COVID-19 Vaccine Distribution and Role of Distribution Industry
January 22, 2021
HDA President and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort.
-
HDA Statement on Biden-Harris Inauguration
-
HDA Statement on Biden Administration COVID-19 Relief and Vaccine Distribution PlanJanuary 16, 2021
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following President-elect Biden’s introduction of a COVID-19 vaccination plan.
-
HDA Research Foundation Names Supply Chain ScholarsJanuary 13, 2021
The HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders.
-
HDA Statement on COVID-19 Emergency Relief PackageDecember 22, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate.
-
HDA Statement on FDA Authorization of Moderna VaccineDecember 18, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization for the Moderna COVID-19 vaccine candidate.
Media Contacts
